Article
Myeloid-Mediated Immunoregulation Across Squamous Cell Carcinomas
2026-07-15
Abstract excerpt
Immune checkpoint inhibitors (ICIs) targeting PD-1/PD-L1 have improved outcomes across squamous cell carcinomas (SCCs) of the head and neck, lung, esophagus, and skin, yet durable responses remain confined to a subset of patients in every subtype. Objective response rates vary substantially across SCCs despite overlapping genomic alterations, comparable tumor mutational burden, and high PD-L1 expression, indicatin...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- de7d931b-e910-55e9-9db4-74795654dd7c
- DOI
- 10.20944/preprints202607.1129.v1
